[Federal Register Volume 65, Number 62 (Thursday, March 30, 2000)]
[Notices]
[Page 16963]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-7873]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 16, 1999, and published in the Federal 
Register on December 28, 1999 (64 FR 248), Knoll Pharmaceuticals, 30 
North Jefferson Road, Whippany, New Jersey 07981, made application by 
renewal to the Drug Enforcement Administration to be registered as a 
bulk manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I
Hydromorphone (9150).......................  II
------------------------------------------------------------------------

    The firm plans to produce bulk product and finished dosage units 
for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Knoll Pharmaceuticals to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Knoll 
Pharmaceuticals on a regular basis to ensure that the company's 
continued registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, audits of the company's records, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed above 
is granted.

    Dated: March 23, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-7873 Filed 3-29-00; 8:45 am]
BILLING CODE 4410-09-M